Pharmacogenomics


Pharmacogenetics is the investigation of microbe line transformations, the single-nucleotide polymorphisms influencing qualities coding for liver proteins liable for drug testimony and pharmacokinetics, though pharmacogenomics alludes to physical changes in tumoral DNA prompting modification in drug reaction KRAS changes in patients treated with hostile to Her1 biologics. Pharmacogenetics is an acquired hereditary contrast in drug metabolic pathways which can influence individual reactions to drugs, both as far as helpful impact just as antagonistic impacts. The term Pharmacogenetics is frequently utilized reciprocally with the term pharmacogenomics which additionally explores the job of gained and acquired hereditary contrasts according to medicate reaction and medication conduct through a precise assessment of qualities, quality items, and between and intra-individual variety in quality articulation and capacity.


  • Functional studies of associated variants or loci
  • Genome-wide association studies
  • Candidate genes/regions and fine mapping
  • Clinical Pharmacogenetics
  • pharmacogenetics and drug-drug interactions
  • Pharmacogenetics in Cardiovascular Medicine
  • Pharmacoepigenetics and Toxic epigenetics

Related Conference of Pharmacogenomics

October 17-18, 2022

21st International Conference on Structural Biology

Barcelona, Spain
November 15-16, 2022

3rd Experts Meeting on Plant, Cellular and Molecular Biology

Budapest, Hungary
November 21-22, 2022

4th Annual summit on Cell Signaling and Cancer Therapy

Montreal, Canada
May 03-04, 2023

16th World Congress on Stem Cell Research

Paris, France
May 03-04, 2023

Global Conference on Cell and Gene Therapy

Paris, France

Pharmacogenomics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in